Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...
Die Merck KGaA befindet sich in fortgeschrittenen Verhandlungen zum Kauf des amerikanischen Krebsspezialisten SpringWorks ...
Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...
SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.
Merck KGaA is in advanced talks to buy US cancer and rare diseases drugmaker SpringWorks Therapeutics Inc., according to a ...
When someone asks where you plan on traveling this year, odds are good Guatemala is not on the itinerary. But for nearly three decades, that’s exactly what two local doctors have been doing, ...
From his TikTok reprieve to sweeping laws on royalties, Donald Trump has been good for musicians. But will they ever be his friends?
Robert F. Kennedy Jr.'s nomination for US health secretary advances with crucial Republican support, despite controversy over ...
President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...
Wall Street rebounds as tech stocks surge, with the S&P 500 up 0.5% amid easing trade tensions and strong corporate earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results